News

Fast Track is a designation that the FDA reserves for a drug intended to treat a serious or life threatening condition and one that demonstrates the potential to

The company, working in close partnership with several major manufacturers, will offer a complete line of nutritional products for patients suffering from complications or circumstances that prevent them

This tranched financing has an immediate draw of $30 million with an additional $10 million available in the first-half of 2009. Concurrent with the financing, Hironori Hozoji, investment

In a double-blind, randomized, controlled trial involving 164 women, Tao Harmony has been shown to reduce hot flash frequency in 83.5% of women. In those women, the number

Mr Jacobson succeeds Gerald Cysewski, who was president and CEO. Dr Cysewski was named executive vice president and chief scientific officer focusing on microalgae product development. He continues

At its initial step, ITGI launches Over and Under pericardium covered stent (PCS) in England, in collaboration with Pyramed, ITGI’s distributor in England. In parallel, the company launches

In connection with the offering, the company expects to grant the underwriters a 30-day option to purchase an additional 1.35 million shares of common stock from the company

The AlmaKnowledgeServer 2 software (AKS2) is a knowledge discovery system based on unique text mining methodologies developed by Bioalma. The Center for Information Technology will use AKS2 to

Under the terms of the Agreement, BioAlliance paid NovaDel a license fee of $3 million upon closing. NovaDel is eligible for additional milestone payments totalling $24 million (an